Asia-Pacific International Center of Excellence in Malaria Research: Maximizing Impact on Malaria Control Policy and Public Health in Cambodia and Papua New Guinea.
Journal
The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507
Informations de publication
Date de publication:
11 10 2022
11 10 2022
Historique:
received:
22
12
2021
accepted:
06
07
2022
entrez:
13
10
2022
pubmed:
14
10
2022
medline:
18
10
2022
Statut:
epublish
Résumé
The Asia-Pacific International Center of Excellence in Malaria Research (ICEMR) was funded in 2016 to conduct a coordinated set of field and in-depth biological studies in Cambodia and Papua New Guinea (PNG), in sites that span the range of transmission intensities currently found in the Asia-Pacific regions. The overall objective is to gain an understanding of key parasite, human host, and vector factors involved in maintaining transmission in the face of intensified control and elimination programs, and to develop novel approaches to identify and target residual transmission foci. In this article, we will describe how the ICEMR program was designed to address key knowledge gaps and priority areas for the malaria control programs in each country. In PNG, partners have worked together on two consecutive ICEMR grants (2009-2016 and 2017-2024) and we present a case study of the partnership and engagement approach that has led to stronger coordination of research activities and integration with program, informing country-level strategic planning and prioritization of control activities. In both settings, the ICEMR program has generated insights into transmission foci, risk factors for ongoing transmission, highlighting the hidden burden of vivax malaria, and the need for additional complementary vector control tools. Finally, we will summarize the emerging research questions and priority areas-namely surveillance, vivax malaria, new vector control tools, and community/health systems-oriented approaches-where further tool development and implementation research have been identified as being needed to guide policy.
Identifiants
pubmed: 36228920
doi: 10.4269/ajtmh.21-1324
pmc: PMC9662209
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
124-130Subventions
Organisme : NIAID NIH HHS
ID : U19 AI129392
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI089686
Pays : United States
Références
Malar J. 2013 Nov 27;12:433
pubmed: 24279720
Bull World Health Organ. 2017 Oct 01;95(10):695-705B
pubmed: 29147042
Nat Med. 2020 May;26(5):741-749
pubmed: 32405064
Sci Rep. 2021 Aug 16;11(1):16540
pubmed: 34400687
BMC Med. 2019 Dec 9;17(1):220
pubmed: 31813381
Malar J. 2014 Jun 24;13:242
pubmed: 24961245
Lancet. 2013 Sep 7;382(9895):900-11
pubmed: 23594387
J Infect Dis. 2021 Apr 27;223(12 Suppl 2):S171-S186
pubmed: 33906224
J Infect Dis. 2017 Dec 12;216(11):1434-1443
pubmed: 29029179
Int J Parasitol Drugs Drug Resist. 2021 Aug;16:188-193
pubmed: 34271323
Malar J. 2020 Jun 5;19(1):198
pubmed: 32503607
Lancet Infect Dis. 2018 Oct;18(10):1108-1116
pubmed: 30170986
Gates Open Res. 2019 Feb 12;3:131
pubmed: 31172051
PLoS Pathog. 2020 Dec 15;16(12):e1009133
pubmed: 33320907
Malar J. 2022 Jan 5;21(1):7
pubmed: 34983530
Nat Commun. 2020 Jul 20;11(1):3646
pubmed: 32686679
Malar J. 2021 Oct 30;20(1):428
pubmed: 34717642